• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由恶性疟原虫引起的人类疟疾中的抗原特异性免疫抑制。

Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum.

作者信息

Ho M, Webster H K, Looareesuwan S, Supanaranond W, Phillips R E, Chanthavanich P, Warrell D A

出版信息

J Infect Dis. 1986 Apr;153(4):763-71. doi: 10.1093/infdis/153.4.763.

DOI:10.1093/infdis/153.4.763
PMID:2936834
Abstract

Proliferative responses of T lymphocytes to antigens specific and not specific for malaria were investigated in 32 adult patients in eastern Thailand during acute infection with Plasmodium falciparum malaria and during their convalescence. Immune unresponsiveness to malarial antigen, which persisted for more than four weeks in 37.5% of the individuals, was present in all patients, irrespective of parasitemia or severity of clinical illness. Suppression of responses to nonspecific antigens was less profound and observed only in patients with moderately severe or cerebral malaria. The depressed functional responses were associated with a loss of T lymphocytes--both helper and suppressor subsets--from the peripheral blood; these responses were recovered once parasites were cleared. These results indicate that blood-stage plasmodial infections may suppress responses important for immunity to malaria and so allow the parasite to survive. They further suggest that patients acutely or even recently infected with P. falciparum may not respond as well to a malaria vaccine as would uninfected individuals.

摘要

在泰国东部的32名成年患者中,研究了他们在感染恶性疟原虫疟疾急性期和恢复期时,T淋巴细胞对疟疾特异性抗原和非特异性抗原的增殖反应。所有患者均存在对疟疾抗原的免疫无反应性,无论其寄生虫血症或临床疾病严重程度如何,37.5%的个体这种无反应性持续超过四周。对非特异性抗原反应的抑制作用较弱,仅在中度严重或脑型疟疾患者中观察到。功能反应的降低与外周血中T淋巴细胞(辅助性和抑制性亚群)的减少有关;一旦寄生虫被清除,这些反应就会恢复。这些结果表明,血期疟原虫感染可能会抑制对疟疾免疫重要的反应,从而使寄生虫得以存活。它们还进一步表明,急性感染甚至近期感染恶性疟原虫的患者对疟疾疫苗的反应可能不如未感染个体。

相似文献

1
Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum.由恶性疟原虫引起的人类疟疾中的抗原特异性免疫抑制。
J Infect Dis. 1986 Apr;153(4):763-71. doi: 10.1093/infdis/153.4.763.
2
Proliferation induced by Plasmodium falciparum antigen and interleukin-2 production by lymphocytes isolated from malaria-immune individuals.恶性疟原虫抗原诱导的增殖以及从疟疾免疫个体分离的淋巴细胞产生白细胞介素-2 。
Infect Immun. 1986 Jul;53(1):221-5. doi: 10.1128/iai.53.1.221-225.1986.
3
Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors.恶性疟原虫疟疾中免疫反应的调节。III. 急性感染患者或免疫供体T细胞体外对抗原的增殖反应及亚群组成
Clin Exp Immunol. 1984 Nov;58(2):380-7.
4
Suppression of parasite-specific response in Plasmodium falciparum malaria. A longitudinal study of blood mononuclear cell proliferation and subset composition.恶性疟原虫疟疾中寄生虫特异性反应的抑制。血液单个核细胞增殖和亚群组成的纵向研究。
Scand J Immunol. 1986 Jul;24(1):73-81. doi: 10.1111/j.1365-3083.1986.tb02071.x.
5
In vitro cell-mediated immune responses to Plasmodium falciparum schizont antigens in adults from a malaria endemic area: CD8+ T lymphocytes inhibit the response of low responder individuals.疟疾流行地区成年人对恶性疟原虫裂殖体抗原的体外细胞介导免疫反应:CD8 + T淋巴细胞抑制低反应个体的反应。
Int Immunol. 1990;2(12):1121-32. doi: 10.1093/intimm/2.12.1121.
6
Suppression of T-cell proliferative response in Plasmodium falciparum malaria patients--preliminary results.
East Afr Med J. 1989 Dec;66(12):787-91.
7
Specific proliferative response of human lymphocytes to purified soluble antigens from Plasmodium falciparum in vitro cultures and to antigens from malaria patients' sera.人淋巴细胞对恶性疟原虫体外培养物中纯化的可溶性抗原以及疟疾患者血清中抗原的特异性增殖反应。
Clin Exp Immunol. 1985 Feb;59(2):421-6.
8
Influence of circulating malarial antigens on cell mediated immunity in acute Plasmodium falciparum malaria.
Acta Trop. 1986 Sep;43(3):255-62.
9
Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.恶性疟原虫血液期抗原Pf155/RESA诱导的人类调节性T细胞反应的特征
Behring Inst Mitt. 1994 Dec(95):97-105.
10
Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.检测对恶性疟原虫红细胞上抗原产生白细胞介素-4的CD4+CD45RO+T淋巴细胞:减毒恶性疟原虫子孢子诱导的保护性免疫的体外相关指标
Cell Immunol. 1997 Sep 15;180(2):143-52. doi: 10.1006/cimm.1997.1186.

引用本文的文献

1
Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials.评估青蒿琥酯单药疗法和双氢青蒿素哌喹作为未来疟疾疫苗现场效力试验期间疫苗接种前根治性治疗的潜在抗疟选择。
Malar J. 2024 Dec 18;23(1):377. doi: 10.1186/s12936-024-05198-1.
2
Genotypic analysis of RTS,S/AS01 malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial.加纳和肯尼亚 5-17 月龄儿童中 RTS,S/AS01 疟疾疫苗的基因型分析,以评估剂量方案和基线疟疾感染状况对寄生虫感染的疗效:一项纵向 2b 期随机对照试验。
Lancet Infect Dis. 2024 Sep;24(9):1025-1036. doi: 10.1016/S1473-3099(24)00179-8. Epub 2024 May 6.
3
Sporozoite immunization: innovative translational science to support the fight against malaria.子孢子免疫接种:支持抗击疟疾的创新转化科学。
Expert Rev Vaccines. 2023 Jan-Dec;22(1):964-1007. doi: 10.1080/14760584.2023.2245890. Epub 2023 Aug 11.
4
infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children.在布基纳法索儿童中,与疟疾候选疫苗 BK-SE36 接种同时发生的感染会干扰免疫反应。
Front Immunol. 2023 Mar 10;14:1119820. doi: 10.3389/fimmu.2023.1119820. eCollection 2023.
5
infection disrupts the T follicular helper cell response to heterologous immunization.感染破坏了 T 滤泡辅助细胞对异源免疫的反应。
Elife. 2023 Jan 30;12:e83330. doi: 10.7554/eLife.83330.
6
PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.PfSPZ-CVac疟疾疫苗在有疟疾感染史的成年人中显示出安全性:一项随机对照1期试验。
EClinicalMedicine. 2022 Jul 30;52:101579. doi: 10.1016/j.eclinm.2022.101579. eCollection 2022 Oct.
7
Immunosuppression in Malaria: Do Parasites Hijack the Host?疟疾中的免疫抑制:寄生虫会劫持宿主吗?
Pathogens. 2021 Oct 3;10(10):1277. doi: 10.3390/pathogens10101277.
8
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial.在肯尼亚西部,婴幼儿接种 PfSPZ 疫苗预防疟疾的安全性、免疫原性和有效性:一项双盲、随机、安慰剂对照的 2 期临床试验。
Nat Med. 2021 Sep;27(9):1636-1645. doi: 10.1038/s41591-021-01470-y. Epub 2021 Sep 13.
9
Malaria Pigment Hemozoin Impairs GM-CSF Receptor Expression and Function by 4-Hydroxynonenal.疟色素疟原虫血红素通过4-羟基壬烯醛损害粒细胞-巨噬细胞集落刺激因子受体的表达和功能。
Antioxidants (Basel). 2021 Aug 6;10(8):1259. doi: 10.3390/antiox10081259.
10
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.在无红细胞期寄生虫血症的情况下给药时,PfSPZ-CVac对疟疾的疗效从0%提高到75%:一项采用人类疟疾感染控制的随机、安慰剂对照试验。
PLoS Pathog. 2021 May 28;17(5):e1009594. doi: 10.1371/journal.ppat.1009594. eCollection 2021 May.